Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

282.31
Delayed Data
As of 9:55am ET
 +0.54 / +0.19%
Today’s Change
244.28
Today|||52-Week Range
303.81
+8.08%
Year-to-Date

Today’s Trading

Previous close281.77
Today’s open280.95
Day’s range280.60 - 284.05
Volume102,468
Average volume (3 months)1,462,251
Market cap$59.6B
Dividend yield--
Data as of 9:55am ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+5.78%
Earnings growth (next 5 years)+6.60%
Revenue growth (last year)+9.37%
P/E ratio18.5
Price/Sales6.09
Price/Book5.01

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc+0.66+0.35%
GILDGilead Sciences+0.17+0.24%
KITEKite Pharma Inc+0.18+0.14%
BIVVBioverativ Inc-0.41-0.74%
Data as of 10:10am ET, 08/21/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$5.62
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts